Ariel Blumovich is a medical business development executive with global work experience in three different continents. Ariel is the Founder & CEO of YDL Ventures.
Ariel lived in Korea for 4 years and worked for Samsung Group on a variety of global business development and strategy roles. During his tenure in Korea, Ariel was a Manager in the team that established Samsung's biopharma business. Along his career Ariel dealt with multi-million dollar deals in the healthcare and hi-technology business lines, including multinational joint-ventures, licensing, sales agreements, and strategic alliances.
Prior to Ariel’s work at Samsung, he worked in Sanofi-Aventis (US) leading a strategic marketing project, Teva Pharmaceuticals (Israel) as Head of Manufacturing Department, and IEC (Israel).
Ariel holds an MBA from Tuck School of Business at Dartmouth, and a B.Sc in Mechanical Engineering from the Technion- Israel Institute of Technology.